A new way to treat immune‑driven disease
Autoimmune and inflammatory diseases arise when the immune system becomes misdirected, attacking the tissues it is meant to protect.
Researchers from City of Hope have developed a “plug-and-play” technology that adds engineered molecules to chimeric antigen receptor T cells after treatment, allowing scientists to better control the cells and redirect them to attack different types of cancer. The preclinical study offers a more flexible way to help CAR T cells keep pace with mutating tumors.
